Bridging Intestinal Failure With Teduglutide - a Case Report

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04916665

Enrollment

Registered

2021-06-07

Start date

2019-01-01

Completion date

2019-12-31

Last updated

2021-06-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Short Bowel Syndrome

Brief summary

In this case report the investigators present a novel strategy for using teduglutide as a bridging therapy to intestinal reconstruction.

Interventions

DRUGTeduglutide

bridging intestinal failure with teduglutide until reconstruction

Study design

Observational model

CASE_ONLY

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

MALE

Inclusion criteria

short bowel syndrome

Exclusion criteria

* \<18 years

Design outcomes

Primary

Measure	Time frame	Description
enteral autonomy (complete discontinuation of parenteral support)	6 months	observe if enteral autonomy may be achieved before reconstruction

Countries

Austria

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026